Franz Worek researcher
Worek, Franz
Worek, Franz, 19..-....
VIAF ID: 45480475 (Personal)
Permalink: http://viaf.org/viaf/45480475
Preferred Forms
- 100 0 _ ‡a Franz Worek ‡c researcher
- 100 1 _ ‡a Worek, Franz
- 100 1 _ ‡a Worek, Franz
-
-
- 100 1 _ ‡a Worek, Franz
-
- 100 1 _ ‡a Worek, Franz, ‡d 19..-....
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Cardiorespiratory function in nerve agent poisoned and oxime + atropine treated guinea-pigs: effect of pyridostigmine pretreatment | |
Chemical warfare toxicology, 2016: | |
Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods | |
Elimination pathways of cyclosarin | |
Evaluation of 6,6'-dithionicotinic acid as alternative chromogen in a modified Ellman method--comparison in various species | |
Evaluation of functional and structural alterations in muscle tissue after short-term cold storage in a new tissue preservation solution | |
Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model | |
Evaluation of the accuracy of "ChE check mobile" in measurement of acetylcholinesterase in pesticide poisoning | |
Extreme variability in the formation of chlorpyrifos oxon (CPO) in patients poisoned by chlorpyrifos (CPF). | |
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents | |
GC-MS and LC-MS analysis of nerve agents in body fluids: intra-laboratory verification test using spiked plasma and urine samples | |
Highly efficient cyclosarin degradation mediated by a β-cyclodextrin derivative containing an oxime-derived substituent | |
Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures | |
Improving the promiscuous nerve agent hydrolase activity of a thermostable archaeal lactonase. | |
In vitro kinetic interactions of DEET, pyridostigmine and organophosphorus pesticides with human cholinesterases | |
In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP). | |
Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation | |
Influence of cyclic and acyclic cucurbiturils on the degradation pathways of the chemical warfare agent VX | |
Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase | |
Innovative Biocatalysts as Tools to Detect and Inactivate Nerve Agents | |
Interaction of bispyridinium compounds with the orthosteric binding site of human α7 and Torpedo californica nicotinic acetylcholine receptors (nAChRs). | |
Intoxication with huperzine A, a potent anticholinesterase found in the fir club moss | |
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. | |
Limitations and challenges in treatment of acute chemical warfare agent poisoning | |
Midazolam is effective to reduce cortical network activity in organotypic cultures during severe cholinergic overstimulation with soman | |
Molar absorption coefficients for the reduced Ellman reagent: reassessment | |
Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients | |
Muscle force and acetylcholinesterase activity in mouse hemidiaphragms exposed to paraoxon and treated by oximes in vitro | |
The NADPH oxidase inhibitor diphenyleneiodonium is also a potent inhibitor of cholinesterases and the internal Ca(2+) pump | |
Nanoparticulate transport of oximes over an in vitro blood-brain barrier model | |
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers | |
Optimized strategies to synthesize β-cyclodextrin-oxime conjugates as a new generation of organophosphate scavengers | |
Paradox findings may challenge orthodox reasoning in acute organophosphate poisoning | |
Photostability of antidotal oxime HI-6, impact on drug development. | |
Poisoning with the S-Alkyl organophosphorus insecticides profenofos and prothiofos. | |
Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial | |
Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro | |
Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning. | |
Quantification of pralidoxime (2-PAM) in urine by ion pair chromatography-diode array detection: application to in vivo samples from minipig. | |
Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase | |
Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach | |
Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status : important indicators for the treatment of patients poisoned by organophosphorus compounds | |
Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6. | |
Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro | |
Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge | |
Simulation of cholinesterase status at different scenarios of nerve agent exposure | |
Simultaneous quantification of the organophosphorus pesticides dimethoate and omethoate in porcine plasma and urine by LC-ESI-MS/MS and flow-injection-ESI-MS/MS. | |
Simultaneous quantification of VX and its toxic metabolite in blood and plasma samples and its application for in vivo and in vitro toxicological studies | |
Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes | |
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun | |
Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6. | |
Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. | |
Tabun scavengers based on hydroxamic acid containing cyclodextrins | |
Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality | |
The therapeutic use of localized cooling in the treatment of VX poisoning | |
Toxicokinetics of tabun enantiomers in anaesthetized swine after intravenous tabun administration | |
Toxicology of organophosphorus compounds in view of an increasing terrorist threat | |
Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model |